List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #20,881 to #20,930.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Ezetimibe/Simvastatin instructions for administration → Vytorin instructions for administration
  2. Ezetimibe/Simvastatin overdose → Vytorin overdose
  3. Ezetimibe/Simvastatin pharmacokinetics and molecular data → Vytorin pharmacokinetics and molecular data
  4. Ezetimibe/Simvastatin precautions → Vytorin precautions
  5. Ezetimibe/Simvastatin side effects → Vytorin side effects
  6. Ezetimibe/simvastatin → Vytorin detailed information
  7. Ezetimibe/simvastatin detailed information → Vytorin detailed information
  8. Ezetimibe adverse reactions → Ezetimibe
  9. Ezetimibe and Simvastatin Combination in the SEAS Trial does Reduce Coronary Artery Events but Not the Progression of Aortic Stenosis → Special:Badtitle/NS100:Ezetimibe and Simvastatin Combination in the SEAS Trial does Reduce Coronary Artery Events but Not the Progression of Aortic Stenosis
  10. Ezetimibe clinical pharmacology → Ezetimibe
  11. Ezetimibe clinical studies → Ezetimibe
  12. Ezetimibe contraindications → Ezetimibe
  13. Ezetimibe description → Ezetimibe
  14. Ezetimibe dosage and administration → Ezetimibe
  15. Ezetimibe dosage forms and strengths → Ezetimibe
  16. Ezetimibe drug interactions → Ezetimibe
  17. Ezetimibe how supplied storage and handling → Ezetimibe#How Supplied
  18. Ezetimibe indications and usage → Ezetimibe
  19. Ezetimibe labels and packages → Ezetimibe
  20. Ezetimibe nonclinical toxicology → Ezetimibe
  21. Ezetimibe overdosage → Ezetimibe
  22. Ezetimibe patient counseling information → Ezetimibe
  23. Ezetimibe use in specific populations → Ezetimibe
  24. Ezetimibe warnings and precautions → Ezetimibe
  25. Ezide → Hydrochlorothiazide
  26. F-actin → Actin
  27. F-center → F-Center
  28. F.A. Davis Company → F. A. Davis Company
  29. F.I.R.E. → Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
  30. F.I.R.E. Study Misses Primary Endpoint → Special:Badtitle/NS100:F.I.R.E. Study Misses Primary Endpoint
  31. F.W. Aston → Francis William Aston
  32. F. necrophorum → Fusobacterium necrophorum
  33. F2R → Coagulation factor II receptor
  34. F508del → ΔF508
  35. F508del-CFTR → ΔF508
  36. FA → Fanconi anemia
  37. FAAH → Fatty acid amide hydrolase
  38. FAAT → Fatty Acid Antiarrhythmia Trial
  39. FACIT → Folate After Coronary Intervention Trial
  40. FACS → Fellow of the American College of Surgeons
  41. FACSM → Fellow of the American College of Sports Medicine
  42. FACT → Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
  43. FAC regimen → CAF regimen
  44. FADH → Flavin
  45. FAH gene → Fumarylacetoacetate hydrolase
  46. FALS → Amyotrophic lateral sclerosis
  47. FAMIS → Fosinopril In Acute Myocardial Infarction Study
  48. FANCC gene → Fanconi anemia, complementation group C
  49. FANCG gene → FANCG
  50. FANTASTIC → Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"